Live Attenuated Influenza Vaccine 2026/2027
A Contract Award Notice
by SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £225M
- Sector
- HEALTH
- Published
- 19 Jun 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
London
Geochart for 2 buyers and 1 suppliers
2 buyers
1 supplier
- Astrazeneca Cambridge
Description
Supply of Live Attenuated Influenza vaccine 2026/2027
Total Quantity or Scope
For the supply of Live Attenuated Influenza Vaccine 2026/2027. Option to extend on two occasions for an additional 12 months on each occasion.
Award Detail
| 1 | Astrazeneca (Cambridge)
|
Renewal Options
Option to extend on two occasions for an additional 12 months on each occasion
Award Criteria
| Social value | _ |
| Risk to programme delivery | _ |
| Comparison with specification | _ |
| Price | _ |
CPV Codes
- 33651660 - Influenza vaccines
Indicators
- Options are available.
- Award on basis of price and quality.
Legal Justification
There is an absence of competition in the market, with only a one supplier capable of delivering the required goods/services to the necessary specification and standards.
Reference
- FTS 058102-2026